Clinical Trial Update: Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose dual therapy to bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-containing quadruple therapy
• High-dose Dual Therapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED